Evidence map›Paper›PMID 40399364›Full record

ArticleScientific reports2025

A new method for analyzing glistenings in hydrophobic acrylic intraocular lenses.

M Canberk Göktepe, Timur M Yildirim, Grzegorz Łabuz, Thibaut Devogelaere, Gerd U Auffarth, Ramin Khoramnia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M Canberk Göktepe *Department of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Timur M Yildirim *Department of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Grzegorz ŁabuzDepartment of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Thibaut DevogelaereDevogelaere Vision, Oudenburg, Belgium.
Gerd U AuffarthDepartment of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Ramin KhoramniaDepartment of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. ramin.khoramnia@ukdd.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A reproducible, examiner-independent, objective method was introduced that uses swept-source optical coherence tomography (SS-OCT) and compared with established methods. Glistenings were induced in-vitro in twenty-five IOLs, five different IOL models: AcrySof SN60WF, AcrySof MA60AC, Clareon CNA0T0, PY60AD and Vivinex XY1. We calculated the glistening density within each IOL using light microscopy and SS-OCT. Glare effects were quantified with a straylight meter device (Oculus C-Quant). Image-processing software provided an objective tool for glistening quantification. Correlation parameters were evaluated between results of the three methods by using linear regression analysis. The PY60AD showed the highest amount of glistenings, followed by the MA60AC and SN60WF, whereas the CNA0T0 and XY1 showed the lowest values. There was a moderate correlation (R

Indexed as

Acrylic ResinsGlareLenses, IntraocularTomography, Optical CoherenceHumansHydrophobic and Hydrophilic InteractionsAcrylic ResinsGlisteningsIntraocular lensesLight microscopyOptical coherence tomographyStraylight

Identifiers

PMID40399364
PMCPMC12095468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.